New Markers of Aortic Stenosis Define Asymptomatic Patients

Asymptomatic aortic stenosis has been keeping us in tense stillness. However, there are new markers capable of identifying patients that might benefit from earlier intervention. In this regard, cardiovascular magnetic resonance (CMR) has been gaining its well-deserved place in cardiology and now more specifically in aortic stenosis. 

Nuevos marcadores de daño en estenosis aórtica que definen pacientes asintomáticos

This study sought to validate CMR markers of prognostic value to aortic stenosis and its thresholds to predict mortality.   

The study prospectively included 799 aortic stenosis patients (n=440 in the derivation cohort and n=359 in the validation cohort) from 13 international centers followed up for nearly 4 years. 

CMR was done shortly before surgical or transcatheter aortic valve replacement (AVR). A forest model was used with 29 variables (13 CMR) capable of predicting mortality and post procedure events. 

There were 52 deaths in the derivation cohort and 51 deaths in the validation cohort. The 4 CMR markers with most predictive power were extracellular volume fraction, late gadolinium enhancement, indexed left ventricular end-diastolic volume, and right ventricular ejection fraction.  

Mortality increased significantly both in the global cohort and among asymptomatic patients when extracellular volume fraction exceeded 27%. 2% of late gadolinium enhancement showed persistent high risk. 


Read also: Anticoagulation with Heparin in Non-Critical COVID-19.


As regards indexed left ventricular end-diastolic volume, increased mortality was also observed at both extremes. High (>80 ml/m2) and low volumes (<55 ml/m2) were mortality predictors.  

There was also increased mortality with high (>80%) and low (≤50%) right ventricular ejection fraction (>80% y <50%).

Predictability improved even further when these 4 markers were combined with clinical factors 


Read also: Heparin Anticoagulation in Critically Ill COVID-19 Patients: Results that Differ from the Rest.


The prognostic thresholds and risk stratification by CMR variables were reproduced in the validation cohort. 

Conclusion

Myocardial fibrosis and biventricular remodeling are the best prognostic factors in patients with aortic stenosis. We should highlight its non-linear association with mortality. 

CMR has the potential to optimize decision making in treating patients with aortic stenosis. 

Original Title: Markers of Myocardial Damage Predict Mortality in Patients With Aortic Stenosis.

Reference: Soongu Kwak et al. J Am Coll Cardiol. 2021 Aug 10;78(6):545-558. doi: 10.1016/j.jacc.2021.05.047.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....